DeepIntent ponies up ad guarantees to take the edge off pharmas' programmatic ad hesitation
Pharma companies still lag other industries when it comes to programmatic advertising use, but the promise of better targeting – and now ad guarantees — may be the incentive carrot to change that.
That’s what DeepIntent is hoping for with advertising guarantees for pharma companies. Using medical claims codes and other de-identified data, the adtech company says it can now precisely quantify how many qualified patients it can reach before, and tally them up after, to show a campaign’s exact reach.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.